ÂÜÀòÂÒÂ×

Dwayne Campogan is a seasoned professional in the field of translational biology with extensive experience at Dendreon Pharmaceuticals since September 2010. As a Senior Research Associate, Dwayne has developed assays involving confocal microscopy and flow cytometry to assess the effectiveness of sipuleucel-T in treating prostate cancer, as well as managing high-throughput ELISA investigations and generating cellular immune response data for clinical trials. Previously, Dwayne worked as a Research Associate in Analytical Development, supporting the advancement of T cell hybridomas and assay development for potency measures. With earlier roles as a Research Technician at Fred Hutchinson Cancer Research Center and as a Lab Technologist at Prolinx, Inc., Dwayne has a solid background in antibody development and applications development, complemented by a Bachelor of Science in Zoology from the University of Washington.